Previous close | 1.1100 |
Open | 0.9500 |
Bid | 0.8500 |
Ask | 1.0500 |
Strike | 33.00 |
Expiry date | 2026-01-16 |
Day's range | 0.9500 - 0.9500 |
Contract range | N/A |
Volume | |
Open interest | 45 |
GSK ( LON:GSK ) First Quarter 2024 Results Key Financial Results Revenue: UK£7.36b (up 5.9% from 1Q 2023). Net income...
Emma Walmsley, chief executive officer of the pharmaceutical firm hailed a ‘strong start to 2024’.
Glaxo (GSK) delivered earnings and revenue surprises of 15.96% and 3.99%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?